CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling
about
Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cellsJanus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.The role of suppressors of cytokine signalling in human neoplasmsCIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulationCish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceCISH and susceptibility to infectious diseasesNegative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3)Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitizationIntegrating signals from the T-cell receptor and the interleukin-2 receptorTranscriptome sequencing of the choroid plexus in schizophreniaThe signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.T-cell development and function are modulated by dual specificity phosphatase DUSP5Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.Suppression of cytokine signaling: the SOCS perspective.Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.SOCS proteins in development and disease.Potential roles of suppressor of cytokine signaling in wound healing.Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis.Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy.CIS is a potent checkpoint in NK cell-mediated tumor immunity.Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization.The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3.Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.Elongin B/C recruitment regulates substrate binding by CIS.Association between single-nucleotide polymorphism in CISH gene and susceptibility to tuberculosis in Chinese Han population.CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility.Dominant TNFα and impaired IL-2 cytokine profiles of CD4+ T cells from children with type-1 diabetes.Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.CIS: the late-blooming eldest son.Unchaining NK cell–mediated anticancer immunosurveillanceRole of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone
P2860
Q24313261-067DCCA4-AA1E-4088-B0AC-E2AA8865E2FFQ24806655-86418FA7-AE80-44BF-84B8-AA3082F1115AQ27026783-0656F0F8-7D17-433C-BF67-A97DB8EBD403Q28140132-9C54AC8F-5DF3-4840-84A1-9F12BF118000Q28141661-2FEAB279-C59B-48B3-A7BF-ADCC2F3B9B5EQ28269352-AF5C81D3-FDB9-49CC-85BD-D7154A2DB658Q28282872-36F509F2-9F26-4E19-9C06-3C74DEB65AE6Q28345510-A1C36111-7B24-4B65-8884-CB5F98730DE3Q28366655-BCAB5B7B-3228-42A8-B4DC-4E95291177C6Q28476433-DAC92A16-D9DE-4B1F-BF18-2087C33F1FC2Q30363952-FC1CB6DF-8C63-471A-862B-B4722446BC12Q33855162-C8C942C2-E59E-4538-AAC1-C928C8E039AFQ33918209-FF1E0DC4-0637-4DCE-9CD8-DD96602DBF81Q33941389-FB0C240A-A782-4C3A-AABF-09CED0ADBD97Q36719234-9B1DA9B4-E4F0-4B3D-9BF1-A87BD2A9D0CBQ37192090-4411A730-BA11-4884-BFE7-17196A29E2EEQ37278469-46D734B1-51E1-474B-9F31-B537C2FCEF4FQ37455362-8DA8F84A-E171-439B-A8DF-999DF8569957Q38124037-8FEA2ABB-205D-4C36-910B-9106299E2133Q38733695-59B6F1F8-7F7F-417D-B943-09167536D7FFQ38875021-26F4B0A5-E335-486C-BE02-CCFB52E6F89EQ39131158-404939D2-6E4F-4F94-B357-D864AF214AF2Q39744193-E7679E4A-BD3F-4955-8120-8E554535DBAAQ40375009-EFBFCEE7-92EF-4AB5-9440-1995BD111ED1Q40778041-364AB054-B580-43AB-BE7D-1459B031BDBFQ42286408-907B6715-E75C-43FE-95F4-F945FB78696FQ46943877-A009F544-1E8B-4557-8065-746C84AD53FBQ47769556-062D2EF1-2CDA-4790-8F4D-BC37775D3A3CQ48093022-279A3CFA-AB25-405A-97E3-7335A6FF162AQ48617204-671C82A7-398B-4583-BAD8-4B4B014A3C55Q50130502-7118CE05-4CDA-402B-B9C2-8D36DF19E3F2Q50896575-3102319F-B9B8-4A53-BBBF-B2B40E5590A7Q57082741-F007C3A9-A56D-47DC-9EDC-68012485C2DFQ58483629-254C8C48-28FA-4784-BE11-F2A6F2BA4420
P2860
CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
CIS associates with the interl ...... erleukin-2-dependent signaling
@ast
CIS associates with the interl ...... erleukin-2-dependent signaling
@en
CIS associates with the interl ...... erleukin-2-dependent signaling
@nl
type
label
CIS associates with the interl ...... erleukin-2-dependent signaling
@ast
CIS associates with the interl ...... erleukin-2-dependent signaling
@en
CIS associates with the interl ...... erleukin-2-dependent signaling
@nl
prefLabel
CIS associates with the interl ...... erleukin-2-dependent signaling
@ast
CIS associates with the interl ...... erleukin-2-dependent signaling
@en
CIS associates with the interl ...... erleukin-2-dependent signaling
@nl
P2093
P2860
P356
P1476
CIS associates with the interl ...... erleukin-2-dependent signaling
@en
P2093
A Miyajima
A Yoshimura
D P Ascherman
E Soldaini
T S Migone
W J Leonard
P2860
P304
30266-30272
P356
10.1074/JBC.274.42.30266
P407
P50
P577
1999-10-01T00:00:00Z